Recent Company News

• 04:39 PM ET Sep 18, 2025
  

  StreetAccount Sector Summary - Healthcare Post-Market

• 09:45 AM ET Sep 18, 2025
  

  Healthcare Notable Decliners

• 08:45 AM ET Sep 18, 2025
  

  StreetAccount Sector Summary - Healthcare Pre-Market

• 06:05 AM ET Sep 18, 2025
  

  Innate Pharma downgraded to neutral from buy at HC Wainwright ($2.05, 0.00)

• 06:24 PM ET Sep 17, 2025
  

  Innate Pharma downgraded to market perform from outperform at Leerink Partners ($2.05, 0.00)

• 09:47 AM ET Sep 17, 2025
  

  Transcript Intelligence: Innate Pharma Q2 Earnings Guidance (€1.76, -0.03)

• 09:47 AM ET Sep 17, 2025
  

  Transcript Intelligence: Innate Pharma Q2 Earnings Q&A (€1.76, -0.03)

• 09:47 AM ET Sep 17, 2025
  

  Transcript Intelligence: Innate Pharma Q2 Earnings Themes (€1.76, -0.03)

• 04:28 AM ET Sep 17, 2025
  

  StreetAccount Summary - Trading higher/lower: EU mid-morning

• 01:04 AM ET Sep 17, 2025
  

  Innate Pharma reports H1 net income (€21.3M) vs FactSet (€26.2M) [1 est] (€1.79, 0.00)